| Alexion Pharma GmbH - Strensiq 40 mg/ml, Injektionslösung |
| 66086 | | 01 | | Strensiq 40 mg/ml | | Injektionslösung | | A16AB13 | | Asfotase Alfa | | 16.08.2016 | | |
|
| Composition |
| asfotasum alfa 40.0 mg, natrii chloridum, dinatrii phosphas heptahydricus, natrii dihydrogenophosphas monohydricus, aqua ad iniectabile q.s. ad solutionem pro 1 ml. |
| Packungsbestandteile |
| Injection solution | | | | | | Active Agent | Dose |
|---|
| Asfotasum Alfa | 40 mg/ml |
| | | | Inactive agents |
|---|
| Disodium Phosphate Heptahydrate | | Sodium Chloride | | Sodium Dihydrogenophosphate Monohydrate |
|
|
|
